Ignite Creation Date:
2024-05-05 @ 9:52 PM
Last Modification Date:
2024-10-26 @ 10:10 AM
Study NCT ID:
NCT00982657
Status:
TERMINATED
Last Update Posted:
2015-11-20
First Post:
2009-09-22
Brief Title:
A Trial Of CVX-060 An Anti-Angiogenic COVX-Body In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
Keywords:
| Name | View |
|---|---|
| Phase Ib Phase II Advanced solid tumor Clear cell renal cancer Sunitinib plus minus CVX-060 | View |